0001213900-23-063797.txt : 20230804 0001213900-23-063797.hdr.sgml : 20230804 20230804214224 ACCESSION NUMBER: 0001213900-23-063797 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230802 FILED AS OF DATE: 20230804 DATE AS OF CHANGE: 20230804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vajdic Branislav CENTRAL INDEX KEY: 0001422425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41060 FILM NUMBER: 231145449 MAIL ADDRESS: STREET 1: 2118 WALSH AVENUE, SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HeartBeam, Inc. CENTRAL INDEX KEY: 0001779372 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 474881450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 408-899-4443 MAIL ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 4 1 ownership.xml X0508 4 2023-08-02 0 0001779372 HeartBeam, Inc. BEAT 0001422425 Vajdic Branislav C/O HEARTBEAM, INC., 2118 WALSH AVENUE, SUITE 210 SANTA CLARA CA 95050 0 1 0 0 CHIEF EXECUTIVE OFFICER 0 Stock option (right to buy) 2.90 2023-08-02 4 A 0 796000 0 A 2023-08-02 2033-08-02 Common Stock 796000 1194000 D The options ("Option" and collectively, "Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on August 1, 2023. The Options will vest and become exercisable with respect to 40% of the shares starting August 1, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam's synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals. /s/ Branislav Vajdic 2023-08-04